The DOI matches its Crossref record; 285 of the 285 references it cites were found in a registry or an index.
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Abstract
IL-17 (interleukin-17), a hallmark cytokine of Th17 (T-helper 17) cells, plays critical roles in host defence against bacterial and fungal infections, as well as in the pathogenesis of autoimmune diseases. The present review focuses on current knowledge of the regulation, functional mechanisms and targeting strategies of IL-17 in the context of inflammatory autoimmune diseases. Evidence shows that IL-17 is highly up-regulated at sites of inflammatory tissues of autoimmune diseases and amplifies the inflammation through synergy with other cytokines, such as TNF (tumour necrosis factor) α. Although IL-17 was originally thought to be produced mainly by Th17 cells, a newly defined T-cell subset with a specific differentiation programme and tight regulation, several other cell types (especially innate immune cells) are also found as important sources for IL-17 production. Although IL-17 activates common downstream signalling, including NF-κB (nuclear factor κB), MAPKs (mitogen-activated protein kinases), C/EBPs (CCAAT/enhancer-binding proteins) and mRNA stability, the immediate receptor signalling has been shown to be quite unique and tightly regulated. Mouse genetic studies have demonstrated a critical role for IL-17 in the pathogenesis of variety of inflammatory autoimmune diseases, such as RA (rheumatoid arthritis) and MS (multiple sclerosis). Importantly, promising results have been shown in initial clinical trials of monoclonal antibodies against IL-17 or its receptor (IL-17R) to block IL-17-mediated function in treating autoimmune patients with psoriasis, RA and MS. Therefore targeting IL-17/IL-17R, IL-17-producing pathways or IL-17-mediated signalling pathways can be considered for future therapy in autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–285 of 285
Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling
Liu, C., Qian, W., Qian, Y., Giltiay, N. V., Lu, Y., Swaidani, S., Misra, S., Deng, L., Chen, Z. J., & Li, X. (2009) · Science Signaling · doi:10.1126/scisignal.2000382 · Cited by 224
Self-citationIL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells
Ciric, B., El-behi, M., Cabrera, R., Zhang, G.-X., & Rostami, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900036 · Cited by 221
Das, J., Ren, G., Zhang, L., Roberts, A. I., Zhao, X., Bothwell, A. L. M., Van Kaer, L., Shi, Y., & Das, G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082286 · Cited by 216
Kimball, A. B. (2008) · Archives of Dermatology · doi:10.1001/archdermatol.2007.63 · Cited by 214
Huang, F., Kao, C.-Y., Wachi, S., Thai, P., Ryu, J., & Wu, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6504 · Cited by 209
Ruddy, M. J., Shen, F., Smith, J. B., Sharma, A., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204065 · Cited by 206
Ets-1 is a negative regulator of Th17 differentiation
Moisan, J., Grenningloh, R., Bettelli, E., Oukka, M., & Ho, I.-C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070994 · Cited by 205
LeGrand, A., Fermor, B., Fink, C., Pisetsky, D. S., Weinberg, J. B., Vail, T. P., & Guilak, F. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9<2078::aid-art358>3.0.co;2-j · Cited by 204
Zhang, X., Jin, J., Peng, X., Ramgolam, V. S., & Markovic-Plese, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6988 · Cited by 201
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195
Laan, M., Lötvall, J., Chung, K. F., & Lindén, A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704063 · Cited by 193
Bulek, K., Liu, C., Swaidani, S., Wang, L., Page, R. C., Gulen, M. F., Herjan, T., Abbadi, A., Qian, W., Sun, D., et al. (2011) · Nature Immunology · doi:10.1038/ni.2080 · Cited by 192
Kyttaris, V. C., Zhang, Z., Kuchroo, V. K., Oukka, M., & Tsokos, G. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903595 · Cited by 188
Koenders, M. I., Kolls, J. K., Oppers‐Walgreen, B., Van Den Bersselaar, L., Joosten, L. A. B., Schurr, J. R., Schwarzenberger, P., Van Den Berg, W. B., & Lubberts, E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21342 · Cited by 186
Chen, Q., Yang, W., Gupta, S., Biswas, P., Smith, P., Bhagat, G., & Pernis, A. B. (2008) · Immunity · doi:10.1016/j.immuni.2008.10.011 · Cited by 186
Targeted depletion of lymphotoxin-α–expressing TH1 and TH17 cells inhibits autoimmune disease
Chiang, E. Y., Kolumam, G. A., Yu, X., Francesco, M., Ivelja, S., Peng, I., Gribling, P., Shu, J., Lee, W. P., Refino, C. J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1984 · Cited by 181
Jain, R., Tartar, D. M., Gregg, R. K., Divekar, R. D., Bell, J. J., Lee, H.-H., Yu, P., Ellis, J. S., Hoeman, C. M., Franklin, C. L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071878 · Cited by 180
Act1, an NF-κB-activating protein
Li, X., Commane, M., Nie, H., Hua, X., Chatterjee-Kishore, M., Wald, D., Haag, M., & Stark, G. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160265197 · Cited by 176
Crispín, J. C., & Tsokos, G. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901533 · Cited by 173
Interleukin 17-Producing γδ T Cells Increased in Patients with Active Pulmonary Tuberculosis
Peng, M., Wang, Z., Yao, C., Jiang, L., Jin, Q., Wang, J., & Li, B. (2008) · Cellular & Molecular Immunology · doi:10.1038/cmi.2008.25 · Cited by 173
IL-17 Induces Monocyte Migration in Rheumatoid Arthritis
Shahrara, S., Pickens, S. R., Dorfleutner, A., & Pope, R. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802246 · Cited by 171
Doisne, J.-M., Becourt, C., Amniai, L., Duarte, N., Le Luduec, J.-B., Eberl, G., & Benlagha, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901059 · Cited by 168
Liu, X. K., Lin, X., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405764200 · Cited by 168
Bai, A., Lu, N., Guo, Y., Liu, Z., Chen, J., & Peng, Z. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0109006 · Cited by 167
Martel-Pelletier, J., Mineau, F., Jovanovic, D., Di Battista, J. A., & Pelletier, J.-P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2399::aid-anr19>3.0.co;2-y · Cited by 165
CIKS, a connection to IκB kinase and stress-activated protein kinase
Leonardi, A., Chariot, A., Claudio, E., Cunningham, K., & Siebenlist, U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190245697 · Cited by 160
Nakae, S., Suto, H., Berry, G. J., & Galli, S. J. (2007) · Blood · doi:10.1182/blood-2006-09-046128 · Cited by 160
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 157
Lubberts, E., Joosten, L. A. B., van de Loo, F. A. J., Schwarzenberger, P. O., Kolls, J., & van den Berg, W. B. (2002) · Inflammation Research · doi:10.1007/bf02684010 · Cited by 152
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Hu, Y., Shen, F., Crellin, N. K., & Ouyang, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05825.x · Cited by 149
IL-17-induced NF-κB Activation via CIKS/Act1
Sønder, S. U., Saret, S., Tang, W., Sturdevant, D. E., Porcella, S. F., & Siebenlist, U. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199547 · Cited by 149
A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α
Laan, M., Prause, O., Miyamoto, M., Sjöstrand, M., Hytönen, A.-M., Kaneko, T., Lötvall, J. O., & Lindén, A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00303503 · Cited by 148
Ichiyama, K., Sekiya, T., Inoue, N., Tamiya, T., Kashiwagi, I., Kimura, A., Morita, R., Muto, G., Shichita, T., Takahashi, R., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.021 · Cited by 144
Zhu, S., Pan, W. Q., Shi, P., Gao, H., Zhao, F., Song, X., Liu, Y., Zhao, L., Li, X., Shi, Y., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100703 · Cited by 144
Self-citationAct1, a negative regulator in CD40- and BAFF-mediated B cell survival
Qian, Y., Qin, J., Cui, G., Naramura, M., Snow, E. C., Ware, C. F., Fairchild, R. L., Omori, S. A., Rickert, R. C., Scott, M., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.001 · Cited by 143
Self-citationClonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis.
Shimonkevitz, R. P., Colburn, C., Burnham, J. A., Murray, R. S., & Kotzin, B. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.923 · Cited by 141
Prause, O., Laan, M., Lötvall, J. O., & Lindén, A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01341-4 · Cited by 139
Sugihara, T., Kobori, A., Imaeda, H., Tsujikawa, T., Amagase, K., Takeuchi, K., Fujiyama, Y., & Andoh, A. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04093.x · Cited by 138
Haudenschild, D. R., Moseley, T. A., Rose, L., & Reddi, A. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109372200 · Cited by 136
IL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain
Shen, F., Li, N., Gade, P., Kalvakolanu, D. V., Weibley, T., Doble, B. W., Woodgett, J. R., Wood, T. D., & Gaffen, S. L. (2009) · Science Signaling · doi:10.1126/scisignal.2000066 · Cited by 135
IL-17 signaling in host defense and inflammatory diseases
Qian, Y., Kang, Z., Liu, C., & Li, X. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.27 · Cited by 124
Self-citationHong, K., Chu, A. D., Ludviksson, B. R., Berg, E. L., & Ehrhardt, R. O. (1999) · PubMed · Cited by 119
Sands, B. E., Jacobson, E. W., Sylwestrowicz, T., Younes, Z., Dryden, G., Fedorak, R., & Greenbloom, S. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21159 · Cited by 114
Hong, K., Chu, A. D., Ludviksson, B. R., Berg, E. L., & Ehrhardt, R. O. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7480 · Cited by 111
IL-17 in Systemic Lupus Erythematosus
Crispín, J. C., & Tsokos, G. C. (2010) · BioMed Research International · doi:10.1155/2010/943254 · Cited by 108
PATHWAYS BY WHICH INTERLEUKIN 17 INDUCES ARTICULAR CARTILAGE BREAKDOWN IN VITRO AND IN VIVO
Cai, L., Yin, J., Starovasnik, M. A., Hogue, D. A., Hillan, K. J., Mort, J. S., & Filvaroff, E. H. (2001) · Cytokine · doi:10.1006/cyto.2001.0939 · Cited by 107
Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17
Cai, X.-Y., Gommoll, C., Justice, L., Narula, S. K., & Fine, J. S. (1998) · Immunology Letters · doi:10.1016/s0165-2478(98)00027-3 · Cited by 101
Fábrega, E., López‐Hoyos, M., Segundo, D. S., Casafont, F., & Pons‐Romero, F. (2009) · Liver Transplantation · doi:10.1002/lt.21724 · Cited by 99
Honorati, M. C., Meliconi, R., Pulsatelli, L., Canè, S., Frizziero, L., & Facchini, A. (2001) · Rheumatology · doi:10.1093/rheumatology/40.5.522 · Cited by 99
Hermann‐Kleiter, N., Gruber, T., Lutz‐Nicoladoni, C., Thuille, N., Fresser, F., Labi, V., Schiefermeier-Mach, N., Warnecke, M., Huber, L. A., Villunger, A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.008 · Cited by 98
Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes
Trajković, V., Stošić‐Grujičić, S., Samardžić, T., Marković, M., Miljković, D. M., Ramić, Z., & Stojković, M. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00391-5 · Cited by 97
IL-17 Signaling for mRNA Stabilization Does Not Require TNF Receptor-Associated Factor 6
Hartupee, J. C., Liu, C., Novotny, M., Sun, D., Li, X., & Hamilton, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1660 · Cited by 93
Klemann, C., Raveney, B. J. E., Klemann, A. K., Ozawa, T., von Hörsten, S., Shudo, K., Oki, S., & Yamamura, T. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081084 · Cited by 93
Loss of IRF-4–binding protein leads to the spontaneous development of systemic autoimmunity
Fanzo, J., Yang, W., Jang, S. Y., Gupta, S. K., Chen, Q., Siddiq, A., Greenberg, T., & Pernis, A. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24096 · Cited by 93
A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87
Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system
Gupta, S. K., Lee, A., Hu, C., Fanzo, J., Goldberg, I., Cattoretti, G., & Pernis, A. B. (2003) · Human Immunology · doi:10.1016/s0198-8859(03)00024-7 · Cited by 86
OR.41. IL-21 and TGF-β are Required for Differentiation of Human Th17 Cells
Anderson, D., Yang, L., Baecher‐Allan, C., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.03.047 · Cited by 83
Yagi, Y., Andoh, A., Inatomi, O., Tsujikawa, T., & Fujiyama, Y. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2091-3 · Cited by 82
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
Patel, A. M., & Moreland, L. (2010) · Drug Design, Development and Therapy · doi:10.2147/dddt.s14099 · Cited by 80
Critical Role for STAT3 in IL-17A-Mediated CCL11 Expression in Human Airway Smooth Muscle Cells
Saleh, A. J., Shan, L., Halayko, A. J., Kung, S. K. P., & GOUNNI, A. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801882 · Cited by 75
A pathogenic role of IL- 17 at the early stage of corneal allograft rejection
Chen, H., Wang, W., Xie, H., Xu, X., Wu, J., Jiang, Z., Zhang, M., Zhou, L., & Zheng, S. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.03.006 · Cited by 74
Qian, Y., Giltiay, N. V., Jianhua, X., Wang, Y., Tian, J., Han, S., Scott, M. L., Carter, R., Jørgensen, T. N., & Li, X. (2008) · European Journal of Immunology · doi:10.1002/eji.200738113 · Cited by 64
Self-citationGenomic Structure and Chromosomal Mapping of the Nuclear Orphan Receptor RORγ (RORC) Gene
Medvedev, A. V., Chistokhina, A., Hirose, T., & Jetten, A. M. (1997) · Genomics · doi:10.1006/geno.1997.4980 · Cited by 64
Actual status of antiinterleukin-1 therapies in rheumatic diseases
Geyer, M., & Müller‐Ladner, U. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283373fa0 · Cited by 62
Möuller, E., Böuhme, J., Abedi‐Valugerdi, M., Ridderstad, A., & Olerup, O. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00811.x · Cited by 58
Liu, C., Swaidani, S., Wen, Q., Kang, Z., Sun, P., Han, Y., Wang, C., Gulen, M. F., Yin, W., Zhang, C., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001843 · Cited by 55
Transcriptional regulation of the Th17 immune response by IKKα
Li, L., Ruan, Q., Hilliard, B. A., DeVirgiliis, J., Karin, M., & Chen, Y. H. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20091346 · Cited by 54
Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice
Pini, M., & Fantuzzi, G. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309188 · Cited by 54
Shi, P., Zhu, S., Lin, Y., Liu, Y., Liu, Y., Chen, Z. J., Shi, Y., & Qian, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001653 · Cited by 53
Self-citationGfi1 negatively regulates Th17 differentiation by inhibiting ROR t activity
Ichiyama, K., Hashimoto, M., Sekiya, T., Nakagawa, R., Wakabayashi, Y., Sugiyama, Y., Komai, K., Saba, I., Möröy, T., & Yoshimura, A. (2009) · International Immunology · doi:10.1093/intimm/dxp054 · Cited by 49
Billich, A. (2007) · PubMed · Cited by 48
Mondal, S., Roy, A., & Pahan, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801734 · Cited by 48
Mölne, L., Corthay, A., Holmdahl, R., & Tarkowski, A. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02151.x · Cited by 47
O’Connor, R. A., Taams, L. S., & Anderton, S. M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04040.x · Cited by 46
Differential Regulation of the IL-17 Receptor by γc Cytokines
Lindemann, M. J., Hu, Z., Benczik, M., Liu, K. D., & Gaffen, S. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801357200 · Cited by 44
Vizier, C., Bercovici, N., Cornet, A. M., Cambouris, C., & Libiau, R. S. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01308.x · Cited by 40
The primacy of CD8 T lymphocytes in type 1 diabetes and implications for therapies
Faustman, D. L., & Davis, M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0516-6 · Cited by 39
The dual nature of Ets-1: Focus to the pathogenesis of systemic lupus erythematosus
Leng, R., Pan, H., Chen, G.-M., Feng, C.-C., Fan, Y., Ye, D., & Li, X.-P. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.01.007 · Cited by 36
Groom, J. R., & Mackay, F. (2008) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100142 · Cited by 30
A 14-yr-old male with dyspnoea, productive cough and chest pain
Rossi, A., Tomà, P., Sacco, O., Fregonese, B., Podestà, E., Dodero, P., Silvestri, G., & Gambini, C. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00101602 · Cited by 29
Yang, K., Wen, J., Liu, X., Kijlstra, A., Chen, L., Chi, W., Zhou, H., Huang, X., & Yang, P. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.142489 · Cited by 22
Interleukin 17-Producing γδ T Cells Increased in Patients with Active Pulmonary Tuberculosis
Mei-yu, Peng, P., Zhaohua, et al. (2008) · 中国免疫学杂志:英文版 · Cited by 21
Kavanaugh, A. (2007) · PubMed · Cited by 20
Ets-1: a new player in the pathogenesis of systemic lupus erythematosus?
Pan, H., Leng, R.-X., Tao, J.-H., Xp, L., & Ye, D. (2011) · Lupus · doi:10.1177/0961203310389842 · Cited by 14
Ricci, M., Rossi, O., Romagnani, S., & Prete, G. (1989) · Autoimmunity · doi:10.3109/08916938908997159 · Cited by 10
Cited by
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
Raphael, I., Nalawade, S., Eagar, T. N., & Forsthuber, T. G. (2015) · Cytokine · doi:10.1016/j.cyto.2014.09.011 · Cited by 1,160
The Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D., He, D., Wang, H., Liu, W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2815 · Cited by 396
Self-citationSong, W., Shen, L., Wang, Y., Liu, Q., Goodwin, T. J., Li, J., Dorosheva, O., Liu, T., Liu, R., & Huang, L. (2018) · Nature Communications · doi:10.1038/s41467-018-04605-x · Cited by 375
Metadata
- Authors
- Zhu, S., & Qian, Y.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2012-02-10
- Volume
- 122
- Issue
- 11
- Pages
- 487-511
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2160247072
- Cited by
- 282
- References
- 285
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.